Report overview
Chronic cough isdefined as a persistent cough that lasts long up to 6-8 weeks. It significantlyaffects the life of the patients by interrupting sleep, creating vomitingsensation, light-headedness, and even rib fractures. It is caused due tomultiple reasons such as infections, asthma, and gastro esophageal refluxdisease (GERD).
This report aims to provide a comprehensive presentation of the global market for Chronic Cough, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Chronic Cough. This report contains market size and forecasts of Chronic Cough in global, including the following market information:
Global Chronic Cough Market Revenue, 2019-2024, 2025-2030, ($ millions)
Global top five companies in 2023 (%)
The global Chronic Cough market was valued at US$ million in 2023 and is projected to reach US$ million by 2030, at a CAGR of % during the forecast period. The influence of COVID-19 and the Russia-Ukraine War were considered while estimating market sizes.
The U.S. Market is Estimated at $ Million in 2023, While China is to reach $ Million.
Oral Segment to Reach $ Million by 2030, with a % CAGR in next six years.
The global key manufacturers of Chronic Cough include Novartis AG, Teva Pharmaceutical Industries Ltd, GlaxoSmithKline, Bayer AG, Mylan N.V., Amneal Pharmaceuticals, Inc., Cipla Inc., Reckitt Benckiser Group and Sun Pharmaceutical Industries Ltd, etc. in 2023, the global top five players have a share approximately % in terms of revenue.
We surveyed the Chronic Cough companies, and industry experts on this industry, involving the revenue, demand, product type, recent developments and plans, industry trends, drivers, challenges, obstacles, and potential risks.
Total Market by Segment:
Global Chronic Cough Market, by Type, 2019-2024, 2025-2030 ($ millions)
Global Chronic Cough Market Segment Percentages, by Type, 2023 (%)
Oral
Injections
Nasal
Others
Global Chronic Cough Market, by Application, 2019-2024, 2025-2030 ($ millions)
Global Chronic Cough Market Segment Percentages, by Application, 2023 (%)
HospitalPharmacy
OnlinePharmacy
RetailPharmacy
Global Chronic Cough Market, By Region and Country, 2019-2024, 2025-2030 ($ Millions)
Global Chronic Cough Market Segment Percentages, By Region and Country, 2023 (%)
North America
US
Canada
Mexico
Europe
Germany
France
U.K.
Italy
Russia
Nordic Countries
Benelux
Rest of Europe
Asia
China
Japan
South Korea
Southeast Asia
India
Rest of Asia
South America
Brazil
Argentina
Rest of South America
Middle East & Africa
Turkey
Israel
Saudi Arabia
UAE
Rest of Middle East & Africa
Competitor Analysis
The report also provides analysis of leading market participants including:
Key companies Chronic Cough revenues in global market, 2019-2024 (estimated), ($ millions)
Key companies Chronic Cough revenues share in global market, 2023 (%)
Further, the report presents profiles of competitors in the market, key players include:
Novartis AG
Teva Pharmaceutical Industries Ltd
GlaxoSmithKline
Bayer AG
Mylan N.V.
Amneal Pharmaceuticals, Inc.
Cipla Inc.
Reckitt Benckiser Group
Sun Pharmaceutical Industries Ltd
Aurobindo Pharma Ltd
Outline of Major Chapters:
Chapter 1: Introduces the definition of Chronic Cough, market overview.
Chapter 2: Global Chronic Cough market size in revenue.
Chapter 3: Detailed analysis of Chronic Cough company competitive landscape, revenue and market share, latest development plan, merger, and acquisition information, etc.
Chapter 4: Provides the analysis of various market segments by type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments by application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6: Sales of Chronic Cough in regional level and country level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space of each country in the world.
Chapter 7: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter 8: The main points and conclusions of the report.
